1
0
0
(1 - 13 von 15
)
[PDF] Polyclonal Antibody to LDLR - Purifiedfnkprddata.blob.core.windows.net › domestic › data › datasheet › ACR
fnkprddata.blob.core.windows.net
Miyamoto, Minako Kaga, Heidi Barth, Thomas F. Baumert, Jean Dubuisson, and Takaji. Wakita CD81 Expression Is Important for the Permissiveness of Huh7 Cell ...
Heidi Barth, Eric Robinet, T. Jake Liang, Thomas F. Baumert - ppt ...slideplayer.com › slide
slideplayer.com
Heidi Barth, Eric Robinet, T. Jake Liang, Thomas F. Baumert Journal of Hepatology Volume 49, Issue 1, Pages (July 2008) DOI: /j.jhep Copyright © Terms and ...
Hepatitis C virus entry: molecular mechanisms and targets for ...www.imrpress.com › journal › FBL › special_issues
www.imrpress.com
Mirjam B. Zeisel, Heidi Barth, Catherine Schuster, Thomas F. Baumert. Front. Biosci. (Landmark Ed) 2009, 14(9), 3274–3285; https://doi.org
Hepatitis C virus entry: molecular mechanisms and HAL-Insermwww.hal.inserm.fr › inserm
www.hal.inserm.fr
Mirjam B. Zeisel, Heidi Barth, Catherine Schuster, Thomas F. Baumert. Hepatitis C virus entry: molecular mechanisms and targets for antiviral therapy.
Development of hepatitis C virus vaccines - HAL-Inserm
www.hal.inserm.fr
von F Stoll-Keller · · Zitiert von: 116 — Françoise Stoll-Keller, Heidi Barth, Samira Fafi-Kremer, Mirjam B. Zeisel, Thomas F. Baumert. Development of hepatitis C virus vaccines: challenges and ... › inserm-...
A look behind closed doors: interaction of persistent viruses with...
hal.archives-ouvertes.fr
Mélanie Lambotin, Sukanya Raghuraman, Françoise Stoll-Keller, Thomas Baumert, Heidi Barth. A look behind closed doors: interaction of persistent viruses ...
Neutralizing antibodies in hepatitis C virus infection. - HAL-Insermwww.hal.inserm.fr › inserm
www.hal.inserm.fr
Mirjam Zeisel 1 Samira Fafi-Kremer 1 Isabel Fofana 1 Heidi Barth 2 Francoise Stoll-Keller 1 Michel Doffoel 3, 4 Thomas Baumert 1, 4, * Détails.
Gale Academic OneFile - Document - Challenges for HCV vaccine...
go.gale.com
Author(s): Mélanie Lambotin 1 2 , Heidi Barth , Christiane Moog 1 2 , François Habersetzer , Thomas F Baumert , Françoise Stoll-Keller [*]
- Document - Development of hepatitis C virus vaccines: challenges...
go.gale.com
Author(s): Françoise Stoll-Keller [[dagger]] 1 , Heidi Barth 2 , Samira Fafi-Kremer 3 , Mirjam B Zeisel 4 , Thomas F Baumert 5. Keywords. : antibody; chimpanzee ...
Toll-like receptor 2 senses hepatitis C virus core protein but not...
pubmed.ncbi.nlm.nih.gov
... Glaucia Paranhos-Baccalà, Françoise Stoll-Keller, Takaji Wakita, Peter Hafkemeyer, Hubert E Blum, Heidi Barth, Philipp Henneke, Thomas F Baumert ...
JCI - Welcome
www.jci.org
Xiping Zhao, Zhen-Ya Tang, Bettina Klumpp, Guido Wolff-Vorbeck, Heidi Barth, Shoshana Levy, Fritz von Weizsäcker, Hubert E. Blum, Thomas F. Baumert. × ...
interaction of persistent viruses with dendritic cells.Inserm
www.hal.inserm.fr
von M Lambotin · · Zitiert von: 95 — Mélanie Lambotin, Sukanya Raghuraman, Françoise Stoll-Keller, Thomas F. Baumert, Heidi Barth. A look behind closed doors: interaction of persistent viruses ... › inser...
Mouse models for the study of HCV infection and virus–host...
cyberleninka.org
Heidi Barth; Eric Robinet; T. Jake Liang; Thomas F. Baumert ... of research paper on Biological sciences, author of scientific article — Heidi Barth, Eric Robinet, ...
Alle Infos zum Namen "Heidi Barth"
sortiert nach Relevanz / Datum